Command Palette
Search for a command to run...
Bhageria Industries
NSE: BHAGERIABSE: 530803CHEMICALS & PETROCHEMICALSDYES & PIGMENTS
Market Cap
--
P/E Ratio
0.00
P/B Ratio
0.00
ROE
0.00%
ROA
0.00%
Debt/Equity
0.00
Book Value
₹0.0
EPS
₹0.0
About Bhageria Industries
Bhageria Industries is an Indian chemical manufacturing company that also has a presence in solar power generation and EPC contracts. They are involved in the production and sale of chemicals, dyes, and dye intermediates.
Bhageria Industries Limited was initially established on July 12, 1989 as 'Bhageria Dye-Chem Limited'. The name of the Company was changed to Bhageria Industries Limited from Bhageria Dye-Chem Limited w.e.f. 16 August, 2015. The Company is engaged in manufacturing and trading of Dyes & Dyes Intermediate, Chemicals and generation and distribution of solar power. Company commenced its operations by setting up a Vinyl Sulphone Plant at Vapi (Gujarat) with capacity of 540 T.P.A. which now expanded to 3600 T.P.A. Subsequently Company went for further expansion in other Dyes intermediates & Dyestuffs. Thereafter, the Company made significant strides in the field of Dye Intermediates and other related products since it's inception. Nearly 70% of its production is being exported worldwide to various clients including multinationals. The products are being exported to Korea, Japan, Taiwan, China, Germany, U.S.A & other European and African countries. Today, Bhageria Dye Chem is one of the largest Manufacturer & Exporter of Intermediates and Dyes. In 2016-17, the Company commissioned a 30MW Solar Power Plant project at Ahmednagar Dist., of Maharashtra and made it operational. It also commissioned other solar power project in Tamil Nadu, Rajasthan and Maharashtra with a capacity of 4.88 MW in 2017. In 2018, Nipur Chemicals Limited was amalgamated with the Company through the Scheme of Arrangement, which became effective from May 3, 2018. In February 2020, it commissioned a Sulphuric Acid Plant at Tarapur with a capacity of 300 TPD. During Financial Year 2021-22, the Company acquired Bhageria & Jajodia Pharmaceuticals Private Limited as a Subsidiary Company on November 25, 2021.
Price Action • BHAGERIA
Financial Statements
Consolidated & Standalone Reports
| Metric | TTM | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 | Mar '15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 725.42 | 604.08 | 511.82 | 505.1 | 605.28 | 403.63 | 419.28 | 467.7 | 378.39 | 357.29 | 240.39 | 415.02 |
Operating Expenses | 617.62 | 513.26 | 451.28 | 446.96 | 480.28 | 295.96 | 316.09 | 337.5 | 287.05 | 284.81 | 211.95 | 356.65 |
Operating Profit | 100.4 | 83.9 | 43.69 | 54.53 | 115.94 | 103.23 | 97.58 | 124.91 | 79.79 | 62.4 | 26.51 | 55.73 |
Operating Margin (%) | - | 13.89 | 8.54 | 10.8 | 19.15 | 25.58 | 23.27 | 26.71 | 21.09 | 17.47 | 11.03 | 13.43 |
Total Expenses | - | 546.32 | 484.46 | 484.38 | 510.14 | 322.83 | 340.73 | 363.49 | 315.98 | 292.4 | 216.64 | 360.26 |
EBITDA | - | 90.82 | 60.54 | 58.14 | 125 | 107.67 | 103.18 | 130.2 | 91.33 | 72.48 | 28.44 | 58.37 |
EBITDA Margin (%) | - | 15.03 | 11.83 | 11.51 | 20.65 | 26.68 | 24.61 | 27.84 | 24.14 | 20.29 | 11.83 | 14.06 |
Interest Expenses | 2.06 | 1.63 | 1.46 | 2.99 | 1.28 | 1.01 | 1.68 | 3.8 | 6.05 | 1.56 | 1.3 | 2.13 |
Depreciation | 31.77 | 31.42 | 31.72 | 34.43 | 28.57 | 25.86 | 22.96 | 22.18 | 22.88 | 6.04 | 3.39 | 1.48 |
Profit Before Tax (PBT) | 73.97 | 57.76 | 27.36 | 20.71 | 95.15 | 80.8 | 78.55 | 104.21 | 62.4 | 64.89 | 23.75 | 54.76 |
Tax Expenses | 20.34 | 15.49 | 7.73 | 5.67 | 24.65 | 18.34 | 12.73 | 32.7 | 22.06 | 21.42 | 8.42 | 18.15 |
PAT Before Extraordinary Items | - | 42.27 | 19.62 | 15.05 | 70.5 | 62.46 | 65.81 | 71.51 | 40.34 | 43.46 | 15.33 | 36.61 |
Net Profit | 53.63 | 42.27 | 19.62 | 15.05 | 70.5 | 62.46 | 65.81 | 71.51 | 40.34 | 43.46 | 15.33 | 36.61 |
Net Profit Margin (%) | - | 7.07 | 3.96 | 3 | 11.82 | 15.64 | 15.9 | 15.46 | 10.99 | 12.51 | 6.42 | 8.87 |
EPS (Adjusted) | - | 9.68 | 4.5 | 3.45 | 16.15 | 14.31 | 15.08 | 16.38 | 9.24 | 9.96 | 3.51 | 8.39 |
Valuation & Key Ratios
Performance Metrics
| Metric | TTM | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 | Mar '15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Book Value Per Share | - | 127.66 | 119.03 | 115.57 | 116.11 | 103.45 | 92.15 | 156.9 | 185.97 | 166.65 | 97.34 | 84.14 |
Return on Assets (ROA) % | - | 5.81 | 2.91 | 2.39 | 11.08 | 10.96 | 12.5 | 15.3 | 8.15 | 8.27 | 10.98 | 29.54 |
Return on Equity (ROE) % | - | 7.58 | 3.77 | 2.98 | 13.91 | 13.83 | 16.36 | 20.88 | 13.65 | 16.42 | 19.77 | 54.63 |
Return on Capital Employed (ROCE) % | - | 9.89 | 5.12 | 4.35 | 17.55 | 16.65 | 17.94 | 27.43 | 19.18 | 21.72 | 28.54 | 82.15 |
Profitability Ratios | - | - | - | - | - | - | - | - | - | - | - | - |
Liquidity Ratios | - | - | - | - | - | - | - | - | - | - | - | - |
Valuation Ratios | - | - | - | - | - | - | - | - | - | - | - | - |
Debt to Equity Ratio | - | 0.06 | 0.07 | 0.07 | 0.03 | 0.06 | 0.05 | 0.07 | 0.28 | 0.54 | 0.15 | 0.25 |
Featured Insight
No recent news available
Key People
M
Mr. Rakesh Kachhadiya
Chief Financial Officer
D
Deepa Toshniwadeepa Toshniwall
Company Secretary,Compliance Officer